A detailed history of Eaton Vance Management transactions in Bio Techne Corp stock. As of the latest transaction made, Eaton Vance Management holds 39,312 shares of TECH stock, worth $3.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
39,312
Previous 36,447 7.86%
Holding current value
$3.14 Million
Previous $12.6 Million 11.63%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $809,477 - $1.12 Million
2,865 Added 7.86%
39,312 $11.2 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $229,095 - $319,251
-710 Reduced 1.91%
36,447 $12.6 Million
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $5.28 Million - $7.28 Million
14,928 Added 67.16%
37,157 $16.1 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $13,228 - $15,226
29 Added 0.13%
22,229 $11.1 Million
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $104,544 - $126,636
-235 Reduced 1.05%
22,200 $10.4 Million
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $273,081 - $317,433
705 Added 3.24%
22,435 $10.1 Million
Q1 2021

May 17, 2021

BUY
$314.62 - $411.0 $43,102 - $56,307
137 Added 0.63%
21,730 $8.3 Million
Q4 2020

Feb 12, 2021

BUY
$246.9 - $321.87 $493,800 - $643,740
2,000 Added 10.21%
21,593 $6.86 Million
Q3 2020

Nov 13, 2020

SELL
$232.22 - $282.96 $156,980 - $191,280
-676 Reduced 3.34%
19,593 $4.85 Million
Q2 2020

Aug 13, 2020

SELL
$185.43 - $279.56 $158,542 - $239,023
-855 Reduced 4.05%
20,269 $5.35 Million
Q1 2020

May 14, 2020

BUY
$161.17 - $221.51 $22,402 - $30,789
139 Added 0.66%
21,124 $4.01 Million
Q2 2019

Aug 16, 2019

BUY
$188.72 - $215.43 $5,850 - $6,678
31 Added 0.15%
20,985 $4.38 Million
Q4 2018

Feb 07, 2019

BUY
$132.75 - $203.8 $1.98 Million - $3.03 Million
14,892 Added 245.66%
20,954 $3.03 Million
Q3 2018

Nov 13, 2018

BUY
$147.44 - $204.11 $6,339 - $8,776
43 Added 0.71%
6,062 $1.24 Million
Q2 2018

Aug 10, 2018

BUY
$144.9 - $165.58 $434 - $496
3 Added 0.05%
6,019 $891,000
Q1 2018

May 07, 2018

BUY
$131.46 - $151.04 $457,612 - $525,770
3,481 Added 137.32%
6,016 $909,000
Q4 2017

Feb 12, 2018

SELL
$121.17 - $134.75 $3,756 - $4,177
-31 Reduced 1.21%
2,535 $329,000
Q3 2017

Nov 13, 2017

BUY
$113.59 - $123.78 $291,471 - $317,619
2,566
2,566 $310,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.13B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.